C12H17NO3
223.27 g/mol
APIWarning
Bufexamac
CAS2438-72-4EC219-451-1
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Bufexamac is a pharmaceutical raw material that has been formulated as an anti-inflammatory agent for topical use. It was historically applied in skin preparations, but its use was restricted in some regions due to reports of allergic reactions.
active pharmaceutical ingredient for topical anti-inflammatory preparationsresearch compound for dermatological studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2438-72-4
Related Compounds
ReferenceSame Category
Doxycycline hydrochloride hemiethanolate hemihydrate
CAS24390-14-5
pharmaceutical raw material
ReferenceSame Category
Sulfadoxine
CAS2447-57-6
pharmaceutical raw material
ReferenceSame Category
Pipamperone hydrochloride
CAS2448-68-2
pharmaceutical raw material
ReferenceSame Category
Cis-terpin hydrate
CAS2451-01-6
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H317May cause an allergic skin reaction
Identifiers
IUPAC Name
2-(4-butoxyphenyl)-N-hydroxyacetamide
InChIKey
MXJWRABVEGLYDG-UHFFFAOYSA-N
SMILES
CCCCOC1=CC=C(C=C1)CC(=O)NO
Synonyms (42)
- J3
- Bufexamac (JAN/INN)
- Bufexamac, European Pharmacopoeia (EP)
- Bufexamaco [INN-Spanish]
- Bufexamacum [INN-Latin]
- Anderm
- Anderm (TN)
- BUFEXAMAC [MART.]
- Bufessamac
- Bufexamac (Standard)
- Bufexamac CRS
- Bufexamaco
- Bufexamacratiopharm
- Bufexamacum
- Bufexamic acid
- CP 1044 J3
- Droxarol
- Droxaryl
- Feximac
- Flogicid
- Flogocid N plastigel
- Malipuran
- Mofenar
- Norfemac
- Paraderm
- Parfenac
- Parfenal
- bufexamac